The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)

Table of Contents

1: Executive Summary

• Introduction
• Scope and Methodology
• Size and Growth of the Market
  • Table 1-1: Global POC Test Market, 2016-2023 (in millions $ at manufacturer level)
• Trends Affecting the Market
• Competitive Outlook
• Market Conclusions
• Conclusion One
• Conclusion Two
• Conclusion Three
• Conclusion Four
• Conclusion Five
• Conclusion Six
• Conclusion Seven

2: Introduction and Overview

• Point-of-Care Diagnostics Testing
• Industry Regulations
• POC Industry Drivers
• Patient focused drivers
• Medical/Healthcare related drivers
• Technology drivers
• Economic drivers
• Other drivers
• POC Test Types
• Blood
• Urine
• Saliva
• Hair
• Optical Technologies
• Breath
• Conditions Evaluated by POC Diagnostic Testing
• Cancer
• Cardiovascular Disease
• Diabetes
• Drug Abuse
• Central Nervous System Stimulants
• Prevalence and Number of Illicit Drug Users
  • Table 2-1: Estimated Number and Prevalence of Drug Users by Region and Age (15-64) (Africa, North America, South America, Asia, Europe, Oceania, Global Total)
• Infectious Disease
• Osteoporosis
• Pregnancy and Fertility

3: POC Blood Glucose Tests

• Types of Blood Glucose Testing
• Fasting Blood Sugar (FBS)
• 2-Hour Postprandial Blood Sugar (PPBS)
• Random Blood Sugar
• Glucose Tolerance Test
• Glucose Urine Test
• Glycated Hemoglobin (HbA1c)
• Products
• Blood Glucose Self-Testing
  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT
• Continuous Self-Testing
• Glycated Hemoglobin Tests
  • Table 3-3: Selected POC HbA1c Devices
• Professional
• Market Size and Growth
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Table 3-5: Global POC Diabetes Sales by Test Category, 2018-2023 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
• Regional Analysis
  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2018-2023 (in millions $ at manufacturer level)
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2018-2023 (in millions $ at manufacturer level)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2018-2023 (in millions $ at manufacturer level)
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2018-2023 (in millions $ at manufacturer level)
• Competitive Analysis
  • Table 3-10: Global POC Blood Glucose Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 3-2: Global POC Glucose Test Manufacturers by Percent, 2018

4: POC Blood and Electrolytes Testing Market

• Types of Blood and Electrolytes Tests
• Hemoglobin/Hematocrit
• WBC
• Blood Gases
• Electrolytes
• Products
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2018
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2018
• Recent Developments
• Market Size and Growth
  • Table 4-3: Global POC Blood and Electrolytes Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Table 4-4: Global POC Blood & Electrolytes Sales by Test Category, 2018-2023 ($ millions) (Blood Gases & Electrolytes [inc critical care], Hematocrit/Hemoglobin, WBC other routine)
• Regional Analysis
  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Blood and Electrolyte Self-Testing
• POC Blood and Electrolyte Professional Testing
  • Table 4-5: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 4-6: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2018

5: POC Rapid Coagulation

• Products
  • Table 5-1: Selected POC Coagulation Innovations
• Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
• Market Size and Growth
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 5-1: POC Rapid Coagulation Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions$)
  • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2018

6: POC Rapid Cardiac Markers

• Products
• Market Size and Growth
  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 6-1: POC Rapid Cardiac Markers Testing Regional Market Analysis, 2018 (US; Europe; Japan; Latin A, AP, India; RoW)
• Competitive Analysis
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2018

7: POC Substance Abuse

• Products
• Urine
• Oral
• Blood
• Hair
• Market Size and Growth
  • Table 7-1: Global POC Drugs of Abuse Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 7-1: POC Substance Abuse Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2018-2023 (includes continuous glucose devices)
• POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2018
  • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2018

8: POC Pregnancy and Fertility Testing

• Products
  • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
• Market Size and Growth
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 8-1: POC Pregnancy and Fertility Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2018

9: POC Colon Cancer Screening/Fecal Occult Blood Testing

• Products
  • Table 9-1: Selected POC Colon Cancer Tests
• Market Size and Growth
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2018

10: POC Infectious Disease Testing

• Products
• HIV and Hepatitis
• Respiratory
• STD
• Tropical Diseases
• Lyme Disease
• TB
  • Table 10-1: Innovations in Molecular POC Infectious Disease Diagnostics
• Market Size and Growth
  • Table 10-2: Global POC Infectious Disease Testing Market Analysis: 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 10-1: POC Infectious Disease Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Infectious Disease Self-Testing
  • Table 10-3: POC Infectious Disease Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Infectious Disease Professional Testing
  • Table 10-4: POC Infectious Disease Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Infectious Disease Testing by Disease Type
  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2018 (in millions $) (Influenza, HIV, STD, Hepatitis, Malaria, C. difficile, E. coli, H. pylori, Home Test/OTC, Others, Total)
• Competitive Analysis
  • Table 10-6: Global POC Infectious Disease Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 10-2: Global POC Infectious Disease Test Manufacturers by Percent, 2018

11: POC Lipid Testing

• Products
• Market Size and Growth
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 11-1: POC Lipid Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Lipid Professional Testing
  • Table 11-3: POC Lipid Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2018

12: POC Cancer Tumor Marker Testing

• Products
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
• Market Size and Growth
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 12-1: POC Cancer Tumor Marker Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2018

13: POC Urine Testing

• Products
• Market Size and Growth
  • Table 13-1: Global POC Urine Testing Market Analysis, 2016-2028 (in millions of dollars at the manufacturer’s level)
• Regional Analysis
  • Figure 13-1: POC Urine Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)
• POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Competitive Analysis
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2018

14: Miscellaneous POC Testing

• Microbiology
• TSH
• Allergy
• Autoimmune
• Others
• Market Size and Growth
  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2016-2023 (in millions of dollars at the manufacturer’s level)
  • Table 14-2: Global POC Miscellaneous Sales by Test Category, 2018-2023 (Microbiology, TSH, Allergy, Autoimmune, Others, Total; $ millions)
• Regional Analysis
  • Figure 14-1: POC Miscellaneous Testing Regional Market Analysis, 2018 (US, Europe, Japan, RoW)

15: Issues and Trends

• Overview
• Wearables
  • Table 15-1: Selected Wearable Devices
• Patient-centered Healthcare
• Breath Test Advances
  • Table 15-2: Selected Disease Markers in Exhaled Breath
• Regulatory Hurdles
• Reimbursement Challenges
• Competition
• POC and Molecular Diagnostics
  • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
• POC and Biosensors and Microfluidics
  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2018
  • Table 15-5: Selected Biochip and Biosensor Players, 2018
• Emerging POC Technologies
• POC Connectivity
• Multiplexed POC Testing
  • Figure 15-1: Multiplexed POC Testing Schematic
• The Emergence of Non-invasive Technologies
• Saliva and Swab
• Optical Techniques

16: Total Global POC Testing Market and Competitor Analysis

• Market Overview
  • Table 16-1: Global POC Test Market, 2016-2023 (in millions $ at manufacturer level)
• Market Analysis by Product Categories
  • Table 16-2: Global POC Testing Market Analysis by Product Category, 2018 (in millions $) (Self-Testing, Professional Testing, Total)
• Market Analysis by Subcategory
• POC Self-Testing
  • Table 16-3: Global POC Self-Testing Market Analysis by Product Category, 2018 (in millions$) (Glucose [includes CGM], Pregnancy & Fertility, Fecal Occult Blood, Rapid Coagulation, Drugs of Abuse, Urine, Infectious Disease, Lipid, Total)
  • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category, 2018 (by %) (Infectious Disease, Urine, Drugs of Abuse [DOA], Coagulation, Fecal Occult Blood [FOB], Pregnancy, Glucose)
• POC Professional Testing
  • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory, 2018 (in millions$) (Drugs of Abuse, Glucose includes HbA1c, Blood & Electrolytes, Infectious Disease, Rapid Coagulation, Fecal Occult Blood, Cardiac Markers, Lipid, Pregnancy & Fertility, Miscellaneous, Urine, Cancer Tumor Markers, Total)
  • Figure 16-2: Global POC Professional Testing Market Analysis by Product Subcategory, 2018 (by %) (Tumor Markers, Urine, Miscellaneous, Pregnancy, Lipid, Cardiac Markers, FOB, Coagulation, Infectious Disease, Blood/Electrolytes, Glucose/HbA1c, DOA)
• POC Testing by End-Use
  • Figure 16-3: POC Testing by End-user, 2018 (%) (Hospitals, Others)
• Market by Device Technology
  • Figure 16-4: Global POC Market by Technology by Sales, 2018 (%) (LFA, Biosensors, Analyzers, Strips)
• Market Analysis by Country
• United States
  • Table 16-5: US POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Europe
  • Table 16-6: Europe POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
  • Table 16-7: Global POC Testing Market Analysis by European Region, 2018 (in millions $) (W. Europe, E. Europe, Total)
  • Figure 16-5: EU POC Testing Percentage Participation, by Country, 2018 (%) (Germany, UK, France, Italy, Switzerland/Sweden, Spain, Other)
• Japan
  • Table 16-8: Japan POC Testing Market Analysis, 2018-2023 (in millions of dollars at the manufacturer’s level)
• Rest of World
  • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country, 2018 (in millions $) (Latin America and Mexico, China, Australia, South Korea, India, Other, Total)
  • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country, 2018 (%) (Latin America/Mexico, China, Australia, South Korea, India, Others)
  • Table 16-10: Global POC Testing Analysis by Region/Country, 2018 (in millions $) (United States, Europe, Japan, ROW, Total)
  • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country, 2018 (US, Europe, Japan, RoW)
• Competitive Analysis
  • Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2018 (in millions $)
  • Figure 16-8: Global POC Testing Market Share by Leading Suppliers, 2018

17: Corporate Profiles

• Overview
• 1 Step Detect Associates, LLC
  • Table 17-1: 1-Step Detect Associates Corporate Summary
• Company Overview
• Products
• Abaxis, Inc.
  • Table 17-2: Abaxis Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-3: Abaxis Revenues 2016-2018 (in thousands $)
• Abbott Laboratories
  • Table 17-4: Abbott Corporate Summary
• Company Overview
• Alere Acquisition Update
• Products
• Performance Review
  • Table 17-5: Abbott Revenues 2016-2018 (in millions $)
• Abingdon Health, Ltd.
  • Table 17-6: Abingdon Health Corporate Summary
• Company Overview
• Products
• AccessBio, Inc.
  • Table 17-7: AccessBio Corporate Summary
• Company Overview
• Products
• AccuBioTech Co, Ltd.
  • Table 17-8: AccuBioTech Corporate Summary
• Company Overview
• Products
• Accutech, LLC
  • Table 17-9: Accutech Corporate Summary
• Company Overview
• Products
• ACON Laboratories, Inc
  • Table 17-10: ACON Laboratories Corporate Summary
• Company Overview
• Products
• Aerscher Diagnostics, LLC
  • Table 17-11: Aerscher Diagnostics Corporate Summary
• Company Overview
• Products
• Akers Biosciences, Inc.
  • Table 17-12: Akers Biosciences Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-13: Akers Corporation Revenue (2015-2018) ($ thousands)
• Alfa Scientific Designs, Inc
  • Table 17-14: Alfa Scientific Corporate Summary
• Company Overview
• Products
• American Bio Medica Corporation
  • Table 17-15: American Bio Medica Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-16: American Bio Medica Corporation Revenue (2015-2018) ($ millions)
• AmniSure International
  • Table 17-17: AmniSure International Corporate Summary
• Company Overview
• Products
• Aquila Diagnostic Systems, Inc
  • Table 17-18: Aquila Diagnostic Systems Summary
• Company Overview
• Products
• Arkray, Inc.
  • Table 17-19: Arkray Corporate Summary
• Company Overview
• Products
• Arlington Scientific, Inc.
  • Table 17-20: Arlington Scientific Corporate Summary
• Company Overview
• Products
• Artron Laboratories, Inc
  • Table 17-21: Artron Laboratories Corporate Summary
• Company Overview
• Products
• Ascensia Diabetes Care Holdings AG
  • Table 17-22: Ascensia Diabetes Care Corporate Summary
• Company Overview
• Products
• Ativa Medical Corporation
  • Table 17-23: Ativa Medical Corporate Summary
• Company Overview
• Products
• Atlas Genetics Ltd. (Binx Health)
  • Table 17-24: Atlas Genetics Corporate Summary
• Company Overview
• Products
• Atlas Link Biotech Co., Ltd
  • Table 17-25: Atlas Link Biotech Corporate Summary
• Company Overview
• Products
• Audit Diagnostics
  • Table 17-26: Audit Diagnostics Corporate Summary
• Company Overview
• Products
• Augurix Diagnostic
  • Table 17-27: Augurix Diagnostic Corporate Summary
• Company Overview
• Products
• Autobio Diagnostics Co., Ltd
  • Table 17-28: Autobio Diagnostics Corporate Summary
• Company Overview
• Products
• Axxin
  • Table 17-29: Axxin Corporate Summary
• Company Overview
• Products
• Beckman Coulter, Inc
  • Table 17-30: Beckman Coulter Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-31: Beckman Coulter Revenue (2015-2018) ($ millions)
• Becton Dickinson (BD)
  • Table 17-32: BD Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-33: BD Corporation Revenue (2015-2018) ($ millions)
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 17-34: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
• Company Overview
• Products
• Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 17-35: Bhat Bio-Tech India Private Corporate Summary
• Company Overview
• Products
• bioLytical Laboratories
  • Table 17-36: bioLytical Laboratories Corporate Summary
• Company Overview
• Products
• BioMedomics, Inc
  • Table 17-37: BioMedomics Corporate Summary
• Company Overview
• Products
• Biomeme, Inc
  • Table 17-38: Biomeme Corporate Summary
• Company Overview
• Products
• Biomerica, Inc.
  • Table 17-39: Biomerica Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-40: Biomerica Corporation Revenue (2015-2018) ($ millions)
• bioMerieux SA
  • Table 17-41: bioMerieux SA Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-42: bioMerieux Revenues (2015-2018) ($ millions)
• Biophor Diagnostics, Inc
  • Table 17-43: Biophor Diagnostics Corporate Summary
• Company Overview
• Products
• Bio-Rad Laboratories Inc.
  • Table 17-44: Bio-Rad Labs Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-45: Bio-Rad Corporation Revenue (2015-2018) ($ millions)
• Bioscan Screening Systems, Inc.
  • Table 17-46: Bioscan Screening Systems Corporate Summary
• Company Overview
• Products
• Biotron Diagnostics, Inc.
  • Table 17-47: Biotron Diagnostics Corporate Summary
• Company Overview
• Products
• Biosensia Ltd.
  • Table 17-48: Biosensia Corporate Summary
• Company Overview
• Products
• BNTX Inc.
  • Table 17-49: BNTX Corporate Summary
• Company Overview
• Products
• Boditech Med Inc
  • Table 17-50: Boditech Med Corporate Summary
• Company Overview
• Products
• Boson Biotech Co. Ltd
  • Table 17-51: Boson Biotech Corporate Summary
• Company Overview
• Products
• Calypte Biomedical Corporation
  • Table 17-52: Calypte Biomedical Corporate Summary
• Company Overview
• Products
• CARE Products, Inc.
  • Table 17-53: CARE Products Corporate Summary
• Company Overview
• Products
• Cepheid, Inc
  • Table 17-54: Cepheid Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-55: Cepheid Revenues (2015-2018) ($ millions)
• Chembio Diagnostic Systems, Inc.
  • Table 17-56: Chembio Diagnostic Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-57: Chembio Diagnostics Revenues (2015-2018) ($ millions)
• Church & Dwight Co. Inc
  • Table 17-58: Church & Dwight Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-59: Church & Dwight Revenues (2015-2018) ($ millions)
• Clarity Diagnostics, LLC
  • Table 17-60: Clarity Diagnostics Corporate Summary
• Company Overview
• Products
• Confirm Biosciences
  • Table 17-61: Confirm Biosciences Corporate Summary
• Company Overview
• Products
• CTK Biotech, Inc.
  • Table 17-62: CTK Biotech Corporate Summary
• Company Overview
• Products
• Daktari Diagnostics
  • Table 17-63: Daktari Diagnostics Corporate Summary
• Company Overview
• Products
• Danaher Corporation
  • Table 17-64: Danaher Corporation Summary
• Company Overview
• Products
• Company Financials
  • Table 17-65: Danaher Revenues (2015-2018) ($ millions)
• Dexcom, Inc
  • Table 17-66: Dexcom Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-67: Dexcom Revenues (2015-2018) ($ millions)
• DIALAB GmbH
  • Table 17-68: DIALAB Corporate Summary
• Company Overview
• Products
• DiaSys Diagnostic Systems GmbH
  • Table 17-69: DiaSys Diagnostic Systems Corporate Summary
• Company Overview
• Products
• Diaxonhit (Eurobio scientific)
  • Table 17-70: Diaxonhit Corporate Summary
• Company Overview
• Products
• Diazyme Laboratories, Inc.
  • Table 17-71: Diazyme Laboratories Corporate Summary
• Company Overview
• Products
• DNA Electronics Ltd. (DNAe)
  • Table 17-72: DNA Electronics Corporate Summary
• Company Overview
• Products
• Dragerwerk AG & Co. KGaA
  • Table 17-73: Dragerwerk Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-74: Dragerwerk Revenues (2015-2018) ($ millions)
• Fooke-Achterrath Laboratorien GmbH
  • Table 17-75: Fooke-Achterrath Laboratorien Corporate Summary
• Company Overview
• Products
• DRG International, Inc.
  • Table 17-76: DRG International Corporate Summary
• Company Overview
• Products
• Eiken Chemical Co Ltd.
  • Table 17-77: Eiken Chemical Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-78: Eiken Chemical Revenues (2015-2018) ($ millions)
• EKF Diagnostics Holdings plc
  • Table 17-79: EKF Diagnostics Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-80: EKF Diagnostics Revenues (2015-2018) ($ millions)
• ELITechGroup, Inc.
  • Table 17-81: ELITechGroup Corporate Summary
• Company Overview
• Products
• Enterix, Inc. (Clinical Genomics)
  • Table 17-82: Enterix Corporate Summary
• Company Overview
• Products
• Entopsis
  • Table 17-83: Entopsis Corporate Summary
• Company Overview
• Products
• Eurolyser Diagnostica GmbH
  • Table 17-84: Eurolyser Diagnostica Corporate Summary
• Company Overview
• Products
• Exact Sciences
  • Table 17-85: Exact Sciences Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-86: Exact Sciences Revenues (2015-2018) ($ millions)
• Exalenz Bioscience Ltd.
  • Table 17-87: Exalenz Bioscience Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-88: Exalenz Bioscience Revenues (2015-2018) ($ millions)
• EY Laboratories
  • Table 17-89: EY Laboratories Corporate Summary
• Company Overview
• Products
• FABPulous B.V.
  • Table 17-90: FABPulous Corporate Summary
• Company Overview
• Products
• Fio Corporation
  • Table 17-91: Fio Corporate Summary
• Company Overview
• Products
• First Check Diagnostics LLC
  • Table 17-92: First Check Diagnostics Corporate Summary
• Company Overview
• Products
• GenBio
  • Table 17-93: GenBio Corporate Summary
• Company Overview
• Products
• Genedrive plc
  • Table 17-94: Genedrive Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-95: Genedrive Revenues (2015-2018) ($ millions)
• GeTein BioMedical, Inc.
  • Table 17-96: GeTein Corporate Summary
• Company Overview
• Products
• GlysBy snc
  • Table 17-97: GlysBy Corporate Summary
• Company Overview
• Products
• Helena Laboratories
  • Table 17-98: Helena Laboratories Corporate Summary
• Company Overview
• Products
• Hema Diagnostic Systems, LLC (NuGenerex Diagnostics)
  • Table 17-99: Hema Diagnostics Systems Corporate Summary
• Company Overview
• Products
• Hemosure, Inc.
  • Table 17-100: Hemosure Corporate Summary
• Company Overview
• Products
• HORIBA, Ltd.
  • Table 17-101: HORIBA Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-102: HORIBA Revenues (2015-2018) ($ millions)
• Immunosciences Lab, Inc.
  • Table 17-103: Immunosciences Lab Corporate Summary
• Company Overview
• Products
• Immunostics, Inc
  • Table 17-104: Immunostics Corporate Summary
• Company Overview
• Products
• InSilixa, Inc
  • Table 17-105: InSilixa Corporate Summary
• Company Overview
• Products
• Instrumentation Laboratory
  • Table 17-106: Instrumentation Laboratory Corporate Summary
• Company Overview
• Products
• JAL Innovation PTE LTD
  • Table 17-107: JAL Innovation Corporate Summary
• Company Overview
• Products
• Jant Pharmacal Corporation
  • Table 17-108: Jant Pharmacal Corporate Summary
• Company Overview
• Products
• Mitra & Co Pvt. Ltd
  • Table 17-109: J Mitra Corporate Summary
• Company Overview
• Products
• LamdaGen Corporation
  • Table 17-110: LamdaGen Corporate Summary
• Company Overview
• Products
• LifeScan, Inc
  • Table 17-111: LifeScan Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-112: LifeScan Revenues (2015-2018 ($ thousands)
• LifeSign, LLC
  • Table 17-113: LifeSign Corporate Summary
• Company Overview
• Products
• Loop Medical
  • Table 17-114 Loop Medical Corporate Summary
• Company Overview
• Products
• Macherey-Nagel GmbH & Co. KG
  • Table 17-115: Macherey-Nagel Corporate Summary
• Company Overview
• Products
• Magnasense Technologies
  • Table 17-116: Magnasense Technologies Corporate Summary
• Company Overview
• Products
• Mbio Diagnostics, Inc
  • Table 17-117: Mbio Diagnostics Corporate Summary
• Company Overview
• Products
• Medix Biochemica
  • Table 17-118: Medix Biochemica Corporate Summary
• Company Overview
• Products
• MedMira, Inc
  • Table 17-119: MedMira Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-120: MedMira Revenues (2015-2018) ($ thousands)
• Medtronic, Inc.
  • Table 17-121: Medtronic Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-122: Medtronic Revenues (2015-2018) ($ millions)
    1. Menarini Diagnostics srl.
  • Table 17-123: Menarini Diagnostics Corporate Summary
• Company Overview
• Products
• Meridian Bioscience, Inc
  • Table 17-124: Meridian Bioscience Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-125: Meridian Bioscience (2015-2018) ($ millions)
• Micronics, Inc
  • Table 17-126: Micronics Corporate Summary
• Company Overview
• Products
• Nano-Ditech Corporation
  • Table 17-127: Nano-Ditech Corporate Summary
• Company Overview
• Products
• Noble Medical, Inc
  • Table 17-128: Noble Medical Corporate Summary
• Company Overview
• Products
• Nova Biomedical, Corp.
  • Table 17-129: Nova Biomedical Corporate Summary
• Company Overview
• Products
• Oasis Diagnostics Corporation
  • Table 17-130: Oasis Diagnostics Corporate Summary
• Company Overview
• Products
• Operon
  • Table 17-131: Operon Corporate Summary
• Company Overview
• Products
• OPKO Health, Inc
  • Table 17-132: OPKO Health Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-133: OPKO Health Revenues (2015-2018) ($ millions)
• OPTI Medical Systems, Inc
  • Table 17-134: OPTI Medical Corporate Summary
• Company Overview
• Products
• OraSure Technologies, Inc.
  • Table 17-135: OraSure Technologies Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-136: OraSure Revenues (2015-2018) ($ millions)
• Polymedco, Inc
  • Table 17-137: Polymedco Corporate Summary
• Company Overview
• Products
• Polymed Therapeutics Inc.
  • Table 17-138: Polymed Therapeutics Corporate Summary
• Company Overview
• Products
• Polymer Technologies, Inc (PTS Diagnostics)
  • Table 17-139: Polymer Technologies Corporate Summary
• Company Overview
• Products
• Preventis GmbH
  • Table 17-140: Preventis Corporate Summary
• Company Overview
• Products
• Princeton Biomeditech Corporation
  • Table 17-141: Princeton Biomeditech Corporate Summary
• Company Overview
• Products
• QuantuMDx Group Limited
  • Table 17-142: QuantuMDx Group Corporate Summary
• Company Overview
• Products
• Quidel Corporation
  • Table 17-143: Quidel Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-144: Quidel Revenues (2015-2018) ($ millions)
• Radiometer Medical A/S
  • Table 17-145: Radiometer Medical Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-146: Radiometer (2015-2018) ($ millions)
• RENESA UG
  • Table 17-147: RENESA UG Corporate Summary
• Company Overview
• Products
• Response Biomedical Corp
  • Table 17-148: Response Biomedical Corporate Summary
• Company Overview
• Products
• Reszon Diagnostics International Sdn. Bhd.
  • Table 17-149: Reszon Diagnostics Corporate Summary
• Company Overview
• Products
• Rheonix, Inc
  • Table 17-150: Rheonix Corporate Summary
• Company Overview
• Products
• Roche Diagnostic Corporation
  • Table 17-151: Roche Diagnostic Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-152: Roche Diagnostics (2015-2018) ($ millions)
• Samsung Healthcare
  • Table 17-153: Samsung Healthcare Corporate Summary
• Company Overview
• Products
• Savyon Diagnostics
  • Table 17-154: Savyon Diagnostics Corporate Summary
• Company Overview
• Products
• Sekisui Diagnostics LLC
  • Table 17-155: Sekisui Diagnostics Corporate Summary
• Company Overview
• Products
• Siemens Healthineers GmbH
  • Table 17-156: Siemens Healthineers Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-157: Siemens Healthineers Revenues (2015-2018) ($ millions)
• Siloam Biosciences, Inc
  • Table 17-158: Siloam Biosciences Summary
• Company Overview
• Products
• Spectral Medical, Inc
  • Table 17-159: Spectral Medical Summary
• Company Overview
• Sysmex Corporation
  • Table 17-160 Sysmex Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-161: Sysmex Revenues (2015-2018) ($ millions)
• TECHLAB, Inc.
  • Table 17-162: TECHLAB Corporate Summary
• Company Overview
• Products
• Teco Diagnostics
  • Table 17-163: Teco Diagnostics Corporate Summary
• Company Overview
• Products
• Trinity Biotech PLC
  • Table 17-164: Trinity Biotech Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-165: Trinity Biotech Revenue (2015-2018) ($ millions)
• Trividia Health
  • Table 17-166: Trividia Health Corporate Summary
• Company Overview
• Products
• Tulip Diagnostics Ltd
  • Table 17-167: Tulip Diagnostics Corporate Summary
• Company Overview
• Product
• Veredus Laboratories PTE Ltd
  • Table 17-168: Veredus Labs Corporate Summary
• Company Overview
• Products
• Vircell
  • Table 17-169: Vircell Corporate Summary
• Company Overview
• Products
• WAMA Diagnostica
  • Table 17-170: WAMA Diagnostica Corporate Summary
• Company Overview
• Products
• Wave 80 Biosciences
  • Table 17-171: Wave 80 Biosciences Corporate Summary
• Company Overview
• Products
• Werfen
  • Table 17-172: Werfen Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-173: Werfen Revenues (2015-2018) ($ millions)